Vitalhub (TSE:VHI) Given a C$7.50 Price Target by Cormark Analysts

Cormark set a C$7.50 price objective on Vitalhub (TSE:VHI) in a research report sent to investors on Monday morning, BayStreet.CA reports. The brokerage currently has a buy rating on the stock.

A number of other research firms have also recently weighed in on VHI. Eight Capital lifted their price objective on Vitalhub from C$5.00 to C$6.25 and gave the company a buy rating in a research report on Tuesday, February 6th. Canaccord Genuity Group lifted their price objective on Vitalhub from C$5.25 to C$5.50 and gave the company a buy rating in a research report on Tuesday, February 6th.

Vitalhub Stock Performance

Shares of TSE:VHI opened at C$6.00 on Monday. The stock has a market capitalization of C$262.26 million, a price-to-earnings ratio of 60.00, a PEG ratio of 0.42 and a beta of 1.21. The stock’s 50-day simple moving average is C$5.99 and its two-hundred day simple moving average is C$4.52. Vitalhub has a 52-week low of C$2.35 and a 52-week high of C$6.86.

Vitalhub (TSE:VHI) last announced its earnings results on Thursday, March 21st. The company reported C$0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of C$0.04 by C($0.01). The firm had revenue of C$13.60 million during the quarter, compared to analysts’ expectations of C$13.68 million. Vitalhub had a return on equity of 5.78% and a net margin of 8.66%. As a group, equities analysts forecast that Vitalhub will post 0.1501823 earnings per share for the current fiscal year.

Vitalhub Company Profile

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.